Toripalimab Combined With Chemotherapy and Bevacizumab as First-Line Treatment in Patients With Advanced Cervical Cancer

NCT04973904 PHASE2 UNKNOWN

This is a single-arm, multicenter, phase II study to investigate efficacy and safety of Toripalimab combined with chemotherapy (paclitaxel and cisplatin) and Bevacizumab as first-line treatment in patients with recurrent, refractory and metastatic cervical cancer

Details

Lead sponsor	Peking Union Medical College Hospital
Phase	PHASE2
Status	UNKNOWN
Enrolment	35
Start date	Sun Aug 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Dec 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Cervical Cancer

Interventions

• Toripalimab
• Paclitaxel
• Cisplatin
• Bevacizumab

Countries

China